J.M.A. de Jong

1.3k total citations
28 papers, 973 citations indexed

About

J.M.A. de Jong is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology. According to data from OpenAlex, J.M.A. de Jong has authored 28 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Otorhinolaryngology. Recurrent topics in J.M.A. de Jong's work include Head and Neck Cancer Studies (9 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Cancer Diagnosis and Treatment (4 papers). J.M.A. de Jong is often cited by papers focused on Head and Neck Cancer Studies (9 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Cancer Diagnosis and Treatment (4 papers). J.M.A. de Jong collaborates with scholars based in Netherlands and United Kingdom. J.M.A. de Jong's co-authors include Johannes A. Langendijk, Neil K. Aaronson, G.J. Hordijk, Emiel F.�M. Wouters, Guul P. M. ten Velde, G.P.M. ten Velde, M. Müller, S. Wanders, Miel Wouters and Matthias Müller and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and European Journal of Cancer.

In The Last Decade

J.M.A. de Jong

28 papers receiving 936 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.M.A. de Jong Netherlands 17 439 432 375 265 113 28 973
Jaiprakash Agarwal India 17 455 1.0× 338 0.8× 587 1.6× 448 1.7× 68 0.6× 42 1.0k
Christos Themelis Greece 9 259 0.6× 330 0.8× 353 0.9× 305 1.2× 53 0.5× 9 760
Quang Luu United States 23 519 1.2× 348 0.8× 843 2.2× 670 2.5× 129 1.1× 46 1.4k
Tai‐Lin Huang Taiwan 15 297 0.7× 226 0.5× 428 1.1× 225 0.8× 38 0.3× 50 752
Rebecca M.W. Yeung China 18 505 1.2× 481 1.1× 541 1.4× 377 1.4× 29 0.3× 35 1.2k
Charles E. Rutter United States 19 483 1.1× 351 0.8× 91 0.2× 206 0.8× 42 0.4× 35 969
Marije R. Vergeer Netherlands 18 308 0.7× 266 0.6× 514 1.4× 287 1.1× 66 0.6× 44 930
B. Fortin Canada 20 382 0.9× 178 0.4× 344 0.9× 254 1.0× 40 0.4× 43 767
Marie A. Emson United Kingdom 12 810 1.8× 312 0.7× 1.0k 2.7× 583 2.2× 118 1.0× 24 1.6k
Irene Karam Canada 19 272 0.6× 265 0.6× 249 0.7× 157 0.6× 28 0.2× 96 836

Countries citing papers authored by J.M.A. de Jong

Since Specialization
Citations

This map shows the geographic impact of J.M.A. de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M.A. de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M.A. de Jong more than expected).

Fields of papers citing papers by J.M.A. de Jong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.M.A. de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M.A. de Jong. The network helps show where J.M.A. de Jong may publish in the future.

Co-authorship network of co-authors of J.M.A. de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of J.M.A. de Jong. A scholar is included among the top collaborators of J.M.A. de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.M.A. de Jong. J.M.A. de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Velazquez, Emmanuel Rios, J.M.A. de Jong, Cary Oberije, et al.. (2011). Development and validation of a nomogram for prediction of survival and local control in laryngeal carcinoma patients treated with radiotherapy alone: A cohort study based on 994 patients. Radiotherapy and Oncology. 100(1). 108–115. 52 indexed citations
2.
Mul, Véronique E., J.M.A. de Jong, L. Murrer, et al.. (2011). Lhermitte sign and myelopathy after irradiation of the cervical spinal cord in radiotherapy treatment of head and neck cancer. Strahlentherapie und Onkologie. 188(1). 71–76. 19 indexed citations
3.
Jong, J.M.A. de, et al.. (2008). Intensity-modulated radiation therapy for oropharyngeal cancer: Radiation dosage constraint at the anterior mandible. Oral Oncology. 45(6). 511–514. 20 indexed citations
4.
Jong, J.M.A. de, et al.. (2006). Predictive Value of Lymph Node Metastases and Extracapsular Extension for the Risk of Distant Metastases in Laryngeal Carcinoma. The Laryngoscope. 116(11). 2067–2070. 32 indexed citations
5.
Brunings, Jan Wouter, Ann Driessen, J.M.A. de Jong, & Johannes J. Manni. (2005). A 15-year-old girl with a spindle cell carcinoma of the parotid gland. A diagnostic challenge solved by immunohistochemistry and cytogenetic analysis. Acta Oto-Laryngologica. 126(1). 104–107. 1 indexed citations
6.
Langendijk, Johannes A., Neil K. Aaronson, J.M.A. de Jong, et al.. (2002). Quality of life after curative radiotherapy in Stage I non-small-cell lung cancer. International Journal of Radiation Oncology*Biology*Physics. 53(4). 847–853. 26 indexed citations
8.
Langendijk, Johannes A., Neil K. Aaronson, J.M.A. de Jong, et al.. (2000). The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiotherapy and Oncology. 55(1). 19–25. 123 indexed citations
9.
Langendijk, Johannes A., G.P.M. ten Velde, Neil K. Aaronson, et al.. (2000). Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. International Journal of Radiation Oncology*Biology*Physics. 47(1). 149–155. 100 indexed citations
10.
Jager, J.J., Lex Volovics, Leo J. Schouten, et al.. (1999). Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation. Radiotherapy and Oncology. 50(3). 267–275. 32 indexed citations
11.
Remarque, Edmond J., et al.. (1999). Dose-dependent antibody response to influenza H1N1 vaccine component in elderly nursing home patients. Experimental Gerontology. 34(1). 109–115. 16 indexed citations
12.
Leeuw, Irma M. Verdonck‐de, Ronald B. Keus, Frans J. M. Hilgers, et al.. (1999). Consequences of voice impairment in daily life for patients following radiotherapy for early glottic cancer: voice quality, vocal function, and vocal performance. International Journal of Radiation Oncology*Biology*Physics. 44(5). 1071–1078. 61 indexed citations
13.
Langendijk, Johannes A., et al.. (1998). Is the chest radiograph a reliable tool in the assessment of tumor response after radiotherapy in nonsmall cell lung carcinoma?. International Journal of Radiation Oncology*Biology*Physics. 41(5). 1037–1045. 11 indexed citations
14.
Langendijk, Johannes A., et al.. (1998). Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor?. Radiotherapy and Oncology. 49(2). 175–183. 49 indexed citations
15.
Poeze, Martijn, M.F. von Meyenfeldt, Johannes L. Peterse, et al.. (1998). Increased proliferative activity and p53 expression in normal glandular breast tissue after radiation therapy. The Journal of Pathology. 185(1). 32–37. 6 indexed citations
16.
Wanders, S., et al.. (1995). Single-dose radiotherapy (6 Gy): palliation in painful bone metastases. Radiotherapy and Oncology. 36(3). 198–202. 43 indexed citations
17.
Langendijk, Johannes A., Erik Thunnissen, R.J.S. Lamers, et al.. (1995). The prognostic significance of accumulation of p53 protein in stage III non-small cell lung cancer treated by radiotherapy. Radiotherapy and Oncology. 36(3). 218–224. 23 indexed citations
18.
Anteunis, Lucien J. C., et al.. (1994). A prospective longitudinal study on radiation-induced hearing loss. The American Journal of Surgery. 168(5). 408–411. 71 indexed citations
19.
Lutgens, Ludy, Bert Schutte, J.M.A. de Jong, & Erik Thunnissen. (1994). DNA Content as Prognostic Factor in Cervix Carcinoma Stage IB-III Treated with Radiotherapy. Gynecologic Oncology. 54(3). 275–281. 10 indexed citations
20.
Sharouni, Sherif Y. El, et al.. (1993). A unique case of intracranial metastasis from lung carcinoma. Clinical Neurology and Neurosurgery. 95(3). 257–260. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026